{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "binds",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:P12821",
      "entity_text" : "angiotensin converting enzyme",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ00212",
      "entity_text" : "SARS-CoV-2",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false,
    "binding_site" : [ "RBD" ],
    "context" : {
      "Species" : [ "taxonomy:9606" ],
      "TissueType" : [ "tissuelist:TS-1297" ],
      "Cellular_component" : [ "go:GO:0016020" ],
      "CellType" : [ "cl:CL:0002063" ]
    }
  },
  "verbose_text" : "Compared to SARS-CoV, the RBD of SARS-CoV-2 binds to angiotensin converting enzyme II (ACE2) more closely and RBD residue changes make binding between the virus and receptor more stable [XREF_BIBR].",
  "reading_complete" : "2020-08-03T13:01:53Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-03T12:56:40Z",
  "trigger" : "binds",
  "evidence" : [ "RBD of SARS-CoV-2 binds to angiotensin converting enzyme" ],
  "pmc_id" : "7382925",
  "score" : 0
}